AZO
55
2
SRE
40
-4
IRM
44
-5
AMGN
23
-7
PEG
51
-7
LEG
27
-4
DUK
55
-5
XYL
39
6
MAR
38
3
CHD
48
-2
PNR
54
3
ABBV
53
-7
ZTS
9
-5
MRK
30
-8
M
27
-3
PEP
45
-2
NOC
47
4
BMY
45
-6
PSX
44
-3
OXY
49
3
AZO
55
2
SRE
40
-4
IRM
44
-5
AMGN
23
-7
PEG
51
-7
LEG
27
-4
DUK
55
-5
XYL
39
6
MAR
38
3
CHD
48
-2
PNR
54
3
ABBV
53
-7
ZTS
9
-5
MRK
30
-8
M
27
-3
PEP
45
-2
NOC
47
4
BMY
45
-6
PSX
44
-3
OXY
49
3
Financhill
Back

iShares US Pharmaceuticals ETF Stock Predictions

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36

IHE
iShares US Pharmaceuticals ETF

Last Price:
$68.91
Seasonality Move:
3.48%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Nuclear Stocks to Buy Before They Surge

Get your report FREE today!

iShares US Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 10.1% based on the past 18 years of stock performance.
  • iShares US Pharmaceuticals ETF has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is iShares US Pharmaceuticals ETF Stock Undervalued?
    The current iShares US Pharmaceuticals ETF [IHE] share price is $69.58. The Score for IHE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • IHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will iShares US Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 10.1% based on the past 18 years of stock performance.

iShares US Pharmaceuticals ETF Stock Rating

Sell
36
iShares US Pharmaceuticals ETF (IHE) is a Sell

Is iShares US Pharmaceuticals ETF overpriced?

  • iShares US Pharmaceuticals ETF has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

iShares US Pharmaceuticals ETF Stock Price History

Is IHE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
73.28
52-Week Low:
62.68

Prediction Charts

Market Cap:
0
Price in USD:
69.58
Volume:
48.8K
Beta:
0.70

Technical Analysis

SMA50:
69.87
SMA100:
68.82
SMA200:
69.09
52-Wk Change:
4.29%

Stock Predictions

  • Is iShares US Pharmaceuticals ETF stock public?
    Yes, iShares US Pharmaceuticals ETF is a publicly traded company.
  • What is the iShares US Pharmaceuticals ETF stock quote today?
    The iShares US Pharmaceuticals ETF stock price is 69.58 USD today.
  • How to buy iShares US Pharmaceuticals ETF stock online?
    You can buy iShares US Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-5 71.90 72.63 72.72 71.65
Mar-6 72.18 72.32 72.51 71.79
Mar-7 72.18 71.86 72.79 71.79
Mar-11 70.93 70.27 70.93 69.77
Mar-12 69.89 69.51 70.01 69.31
Mar-13 69.51 68.93 69.63 68.91
Mar-14 69.09 69.32 69.39 68.98
Mar-17 69.32 70.15 70.37 69.32
Mar-18 69.94 70.01 70.16 69.66
Mar-19 70.02 70.25 70.41 69.90
Mar-20 70.24 70.39 70.64 70.11
Mar-21 70.26 70.21 70.52 70.04
Mar-24 70.46 70.94 70.99 70.46
Mar-25 71.22 69.58 71.22 69.44

iShares US Pharmaceuticals ETF Earnings

Data Unavailable

iShares US Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* iShares US Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.